Updated Jul 16, 2026
Mulligan Seamus has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $9.99M. Historical track record: 5/5 stars across 4 tracked purchases.

| Role | Director |
|---|---|
| Notability | 20/100 |
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.
| InsiderAlpha rating | ★★★★★ (5/5) |
|---|---|
| Total purchases tracked | 4 |
| Purchases with forward-return data | 4 |
| 30-day win rate | 10000% |
| 90-day win rate | 10000% |
| Avg 5-day return | +825.39% |
| Avg 30-day return | +1247.76% |
| Avg 90-day return | +1269.90% |
| Best 30-day return | +1440.99% |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-01 | JAZZ | Jazz Pharmaceuticals plc | M — Option exercise | 3.4K | $138.08 | $472K |
| 2025-08-07 | JAZZ | Jazz Pharmaceuticals plc | A — Grant or award | 3.5K | $0.00 | |
| 2025-05-09 | JAZZ | Jazz Pharmaceuticals plc | P — Open-market purchase | 1.6K | $103.00 | $167K |
| 2025-05-09 | JAZZ | Jazz Pharmaceuticals plc | P — Open-market purchase | 100 | $99.71 | $10K |
| 2025-05-09 | JAZZ | Jazz Pharmaceuticals plc | P — Open-market purchase | 19.2K | $98.91 | $1.90M |
| 2025-05-09 | JAZZ | Jazz Pharmaceuticals plc | P — Open-market purchase | 80.7K | $98.10 | $7.92M |
Mulligan Seamus is a corporate insider — currently tracked as Director of Jazz Pharmaceuticals plc (JAZZ). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 4 open-market purchases ($9.99M) and 0 open-market sales () across all tracked filings.
Across 4 tracked purchases, Mulligan Seamus averaged +1247.8% avg 30-day return with a 10000% 30-day win rate. InsiderAlpha rates the track record at 5/5 stars.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Mulligan Seamus profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.